Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
Clinical trial NCT04854499 · TERMINATED
Trial details
- NCT number
- NCT04854499
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2024-10-02
- Enrollment
- 193
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.